Ethical and Legal Acceptability of the Use of Neuromuscular Blockers (NMBs) in Connection With Abstention Decisions in Dutch NICUs: Interviews With Neonatologists
Journal of medical ethics 2011 Jan; 37(1): 29-33
In the Netherlands, using drugs to deliberately end the life of a severely defective newborn baby who is in extreme suffering can be permissible under very precise circumstances. This does not mean that all Dutch neonatologists are willing to engage in such behaviour. This paper discusses the use of neuromuscular blockers (NMBs) in connection with abstention decisions in neonatology and the boundaries between 'deliberate ending of life' and other end-of-life decisions. These boundaries are of paramount importance because, of all end-of-life decisions, only 'deliberate ending of life' must be reported by the responsible doctor and exposes him to the risk of being prosecuted.
Showing items related by title, author, creator and subject.
Non-Treatment Decisions on Grounds of "Medical Futility" and "Quality of Life": Interviews With Fourteen Dutch Neonatologists Moratti, Sofia (2010-06)This essay opens with background information about the concept of "medical futility" and the regulation of nontreatment decisions in Dutch neonatology. The regulations include a list of criteria for predicting the baby's ...
The Parents' Ability to Take Care of Their Baby as a Factor in Decisions to Withhold or Withdraw Life-Prolonging Treatment in Two Dutch NICUs Moratti, Sofia (2010-06)In The Netherlands, it is openly acknowledged that the parents' ability to take care of their child plays a role in the decision-making process over administration of life-prolonging treatment to severely defective newborn ...
Moratti, Sofia (2010-12)This contribution describes the regulation of end-of-life decisions in neonatology in the Netherlands. An account is given of the process of formulating rules, which includes a report by the Dutch Association for Paediatrics, ...